НЕФРОГЕН АРТЕРИАЛ ГИПЕРТЕНЗИЯ БИЛАН АСОРАТЛАНГАН СУРУНКАЛИ БУЙРАК КАСАЛЛИКЛАРНИ ЗАМОНАВИЙ ДАВОЛАШ УСЛУБЛАРИ

Objective: to estimate the comparative aspect of the influence of amlodipine and Nebilet for remodeling heart patients with CKD stage III with moderate nephrogenic hypertension. MATERIALS AND METHODS: The study included 40 patients with renal arterial hypertension, which developed due to chronic kidney disease. RESULTS: The study found patients with CKD stage III with moderate nephrogenic hypertension has a violation of intracardiac hemodynamics. CONCLUSIONS: These data show an improvement of intracardiac hemodynamics in all patients after 3-month therapy with amlodipine and nebilet.